Aller au contenu principal
2024 conference-abstract

S2251 The Impact of Low-FODMAP Diet in Managing Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis

0Citations signalées — pas une note de qualité
5Institutions déclarées
2Pays d’affiliation déclarés

Résumé fourni par la source

Introduction: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by abdominal pain, bloating, and changes in bowel habits. Increasing evidence suggests effectiveness of the low-fermentable oligo-, di-, and monosaccharides, and polyols(FODMAP) diet in managing IBS symptoms. Therefore, we evaluated the impact of the low FODMAP diet on IBS symptom severity and quality of life (QoL) in IBS patients. Methods: We conducted a comprehensive search on the PubMed and SCOPUS databases from inception until June 8, 2024, for studies evaluating the effects of low-FODMAP diet on IBS symptom severity assessed by the IBS severity scoring system (IBS-SSS) and QoL assessed by the IBS-QoL questionnaire. The data were represented as mean differences for these continuous outcomes. Meta-analyses were performed for the quantitative analyses using random-effects models with inverse variance weighing. Results: Our meta-analysis included 15 studies with total of 1,198 participants. The pooled analysis demonstrated that patients on low-FODMAP diet experienced decrease in IBS-SSS compared to those on control diet (MD -49.91; 95% CI -76.94, -22.89; I2 = 89%, Figure 1A). Additionally, low-FODMAP diet significantly improved IBS-QoL scores compared to a control diet (MD 5.51; 95% CI 3.16, 7.85; I2 = 32%, Figure 1A). Conclusion: The low-FODMAP diet reduces IBS symptom severity and enhances QoL in individuals with IBS. These findings underscore the potential of the low-FODMAP diet as an effective treatment for managing IBS symptoms.Figure 1.: A) Effect of low-FODMAP diet on IBS-SSS in patients with IBS. B) Effect of low-FODMAP diet on QoL values in patients with IBS. FODMAP, fermentable oligo-, di-, and monosaccharides, and polyols; IBS-SSS, IBS severity scoring system; IBS, irritable bowel syndrome; QoL, quality of life.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
S2251 The Impact of Low-FODMAP Diet in Managing Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis
Date Crossref
01/10/2024
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Gastrointestinal motility and disordersChild Nutrition and Feeding Issues

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.